Paper14749129
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.
Lepourcelet M and 8 others. Cancer Cell, 2004. Cited by 563 papers, by iCite.
Cite this record
ConductScience Library. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Papers, record 14749129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14749129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytoskeletal Proteins | Major topic |
| DNA-Binding Proteins | Major topic |
| Signal Transduction | Major topic |
| Trans-Activators | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| COS Cells | |
| Cell Division | |
| Chlorocebus aethiops | |
| Combinatorial Chemistry Techniques | |
| Cyclin D1 | |
| Protein Binding | |
| Surface Plasmon Resonance | |
| Xenopus | |
| Xenopus Proteins | |
| beta Catenin |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA52955 | NCI NIH HHS | United States | U01CA052955 | PubMed and NIH | NIH RePORTER |
| U19CA052955 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 14749120 | Wnt breakers in colon cancer. | https://conductscience.org/library/papers/14749120 |
Source PubMed
Cited by287
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 563 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902746 | Natural products shape microbial ecology and disease in the cystic fibrosis airway. | Nat Prod Rep | 2026 | https://conductscience.org/library/papers/42902746 | PubMed |
| 41879495 | Emerging Roles of Small-molecule Derivatives in Modulating Neurodegenerative Pathways: From Molecular Targets to Therapeutic Applications. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41879495 | PubMed |
| 41714442 | The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/41714442 | PubMed |
| 41416436 | CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/41416436 | PubMed |
| 41408288 | Nuclear β-catenin: molecular regulation, challenges and therapeutic opportunities. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41408288 | PubMed |
| 41132024 | Downregulation of the Tumor Suppressor P53 Gene associated with the Progression of Clinical Staging and the Incidence of Distant Metastasis in Indonesian Colorectal Cancer. | Korean J Gastroenterol | 2025 | https://conductscience.org/library/papers/41132024 | PubMed |
| 41120801 | WNT signaling in cancer: molecular mechanisms and potential therapies. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41120801 | PubMed |
| 40704280 | Molecular mechanisms underlying the inhibition of cell migration and invasion in endometriosis: Advances in pharmacological research (Review). | Biomed Rep | 2025 | https://conductscience.org/library/papers/40704280 | PubMed |
| 40240755 | Perspectives on cancer therapy-synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40240755 | PubMed |
| 40180907 | Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40180907 | PubMed |
| 40078400 | Exploring the therapeutic potential of "Zhi-Zhen" formula for oxaliplatin resistance in colorectal cancer: an integrated study combining UPLC-QTOF-MS/MS, bioinformatics, network pharmacology, and experimental validation. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40078400 | PubMed |
| 39766864 | Wnt Signaling Pathway in Tumor Biology. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39766864 | PubMed |
| 39725462 | Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma. | Gut | 2025 | https://conductscience.org/library/papers/39725462 | PubMed |
| 39614036 | Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions. | Drug Deliv Transl Res | 2025 | https://conductscience.org/library/papers/39614036 | PubMed |
| 39529066 | Emerging roles and biomarker potential of WNT6 in human cancers. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39529066 | PubMed |
| 39404999 | Combinatorial Effects of 5-Fluorouracil and Menadione on Wnt/β-Catenin Pathway in Human Colorectal Cancer Cells. | Appl Biochem Biotechnol | 2025 | https://conductscience.org/library/papers/39404999 | PubMed |
| 38886806 | Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/38886806 | PubMed |
| 38045829 | Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/38045829 | PubMed |
| 37783294 | Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. | Gene | 2024 | https://conductscience.org/library/papers/37783294 | PubMed |
| 37749246 | Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities. | Nat Genet | 2023 | https://conductscience.org/library/papers/37749246 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| TCF4 | 6925 | PubTator's text mining | https://conductscience.org/library/genes/6925 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14749129
GET https://conductscience.org/api/papers/v1/14749129/cited_by?page=2